SCHEMBL5899482

SCHEMBL5899482

O=C(CNS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.60
FLT1 P17948 1/20 0.60
FLT4 P35916 1/20 0.60
KDR P35968 1/20 0.60
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MEP1B Q16820 2/20 0.56
KAT6A Q92794 2/20 0.56
GAA P10253 3/20 0.54
MMP1 P03956 3/20 0.54
MMP12 P39900 2/20 0.54
MAPT P10636 1/20 0.53
HSD11B1 P28845 2/20 0.53
ALDH1A1 P00352 1/20 0.52
TP53 P04637 1/20 0.52
PRMT1 Q99873 1/20 0.51
MMP2 P08253 1/20 0.50
MMP3 P08254 1/20 0.50
MMP7 P09237 1/20 0.50
MMP9 P14780 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23014305 0.92 MEP1B (0.60) L3MBTL1FLT1FLT4KDRMEP1B
SCHEMBL5899544 0.89 KAT6A (0.58) MEN1KMT2AMEP1BKAT6AGAA
SCHEMBL2838364 0.88 MMP1 (0.64) MEP1BKAT6AMMP1MAPTMMP2
SCHEMBL23014492 0.85 KMT2A (0.59) L3MBTL1FLT1FLT4KDRKMT2A
SCHEMBL23014406 0.85 EGFR (0.55) FLT1FLT4KDRMEN1KMT2A
SCHEMBL23014361 0.84 KAT6A (0.58) MEN1KMT2AMEP1BKAT6AGAA
SCHEMBL5320466 0.84 ALDH1A1 (0.60) L3MBTL1MEN1KMT2AKAT6AGAA
SCHEMBL5899737 0.84 MMP1 (0.63) MEN1KMT2AMEP1BKAT6AGAA
SCHEMBL9777986 0.84 TBXA2R (0.67) L3MBTL1FLT1FLT4KDRMEP1B
SCHEMBL5899421 0.83 KAT6A (0.65) L3MBTL1FLT1FLT4KDRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 L3MBTL1 1816/4885FLT1 3175/4885FLT4 4411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.